184 related articles for article (PubMed ID: 23203541)
1. Chronic exposure of lung alveolar epithelial type II cells to tobacco-specific carcinogen NNK results in malignant transformation: a new in vitro lung carcinogenesis model.
Mennecier G; Torres LN; Cogliati B; Sanches DS; Mori CM; Latorre AO; Chaible LM; Mackowiak II; Nagamine MK; Da Silva TC; Fukumasu H; Dagli ML
Mol Carcinog; 2014 May; 53(5):392-402. PubMed ID: 23203541
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Zhou H; Calaf GM; Hei TK
Int J Cancer; 2003 Oct; 106(6):821-6. PubMed ID: 12918058
[TBL] [Abstract][Full Text] [Related]
3. Long-term exposure to extremely low-dose of nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induce non-malignant breast epithelial cell transformation through activation of the a9-nicotinic acetylcholine receptor-mediated signaling pathway.
Fararjeh AS; Tu SH; Chen LC; Cheng TC; Liu YR; Chang HL; Chang HW; Huang CC; Wang HR; Hwang-Verslues WW; Wu CH; Ho YS
Environ Toxicol; 2019 Jan; 34(1):73-82. PubMed ID: 30259641
[TBL] [Abstract][Full Text] [Related]
4. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.
Belinsky SA; Devereux TR; Foley JF; Maronpot RR; Anderson MW
Cancer Res; 1992 Jun; 52(11):3164-73. PubMed ID: 1591728
[TBL] [Abstract][Full Text] [Related]
5. Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK.
Mei J; Hu H; McEntee M; Plummer H; Song P; Wang HC
Breast Cancer Res Treat; 2003 May; 79(1):95-105. PubMed ID: 12779086
[TBL] [Abstract][Full Text] [Related]
6. Involvement of m6A regulatory factor IGF2BP1 in malignant transformation of human bronchial epithelial Beas-2B cells induced by tobacco carcinogen NNK.
Zhou J; Xiong R; Zhou J; Guan X; Jiang G; Chen Y; Yang Q
Toxicol Appl Pharmacol; 2022 Feb; 436():115849. PubMed ID: 34974052
[TBL] [Abstract][Full Text] [Related]
7. Development of ferret as a human lung cancer model by injecting 4-(Nmethyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Aizawa K; Liu C; Veeramachaneni S; Hu KQ; Smith DE; Wang XD
Lung Cancer; 2013 Dec; 82(3):390-6. PubMed ID: 24396883
[TBL] [Abstract][Full Text] [Related]
8. Understanding tobacco smoke carcinogen NNK and lung tumorigenesis.
Akopyan G; Bonavida B
Int J Oncol; 2006 Oct; 29(4):745-52. PubMed ID: 16964372
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells.
Schrader E; Hirsch-Ernst KI; Scholz E; Kahl GF; Foth H
Drug Metab Dispos; 2000 Feb; 28(2):180-5. PubMed ID: 10640516
[TBL] [Abstract][Full Text] [Related]
10. Precancerous model of human breast epithelial cells induced by NNK for prevention.
Siriwardhana N; Choudhary S; Wang HC
Breast Cancer Res Treat; 2008 Jun; 109(3):427-41. PubMed ID: 17653854
[TBL] [Abstract][Full Text] [Related]
11. [Malignant transformation of HPV-18 immortalized human bronchial epithelial cells induced by tobacco-specific nitrosamine NNK].
Sun H; Gong Y; Wang Q; Chen J
Wei Sheng Yan Jiu; 1999 Mar; 28(2):95-6. PubMed ID: 11939015
[TBL] [Abstract][Full Text] [Related]
12. Ethanol and the tobacco-specific carcinogen, NNK, contribute to signaling in immortalized human pancreatic duct epithelial cells.
Askari MD; Tsao MS; Cekanova M; Schuller HM
Pancreas; 2006 Jul; 33(1):53-62. PubMed ID: 16804413
[TBL] [Abstract][Full Text] [Related]
13. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation.
Ho YS; Chen CH; Wang YJ; Pestell RG; Albanese C; Chen RJ; Chang MC; Jeng JH; Lin SY; Liang YC; Tseng H; Lee WS; Lin JK; Chu JS; Chen LC; Lee CH; Tso WL; Lai YC; Wu CH
Toxicol Appl Pharmacol; 2005 Jun; 205(2):133-48. PubMed ID: 15893541
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Circ_0035266 Contributes to the Malignant Progression of Inflammation-Associated Malignant Transformed Cells Induced by Tobacco-Specific Carcinogen NNK.
Hua Q; Liu Y; Li M; Li X; Chen W; Diao Q; Ling Y; Jiang Y
Toxicol Sci; 2022 Sep; 189(2):203-215. PubMed ID: 35866630
[TBL] [Abstract][Full Text] [Related]
15. Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms.
Ge GZ; Xu TR; Chen C
Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):477-87. PubMed ID: 26040315
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice.
Li MY; Kong AW; Yuan H; Ma LT; Hsin MK; Wan IY; Underwood MJ; Chen GG
Curr Cancer Drug Targets; 2012 Jul; 12(6):597-606. PubMed ID: 22463586
[TBL] [Abstract][Full Text] [Related]
17. Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.
Stabile LP; Rothstein ME; Cunningham DE; Land SR; Dacic S; Keohavong P; Siegfried JM
Carcinogenesis; 2012 Nov; 33(11):2181-9. PubMed ID: 22859269
[TBL] [Abstract][Full Text] [Related]
18. Higher susceptibility of spontaneous and NNK-induced lung neoplasms in connexin 43 deficient CD1 × AJ F1 mice: paradoxical expression of connexin 43 during lung carcinogenesis.
Fukumasu H; Avanzo JL; Sanches DS; Mennecier G; Mori CM; Dagli ML
Mol Carcinog; 2013 Jul; 52(7):497-506. PubMed ID: 22344786
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/ 64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Oct; 440():1-314. PubMed ID: 12595923
[TBL] [Abstract][Full Text] [Related]
20. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells.
Tsurutani J; Castillo SS; Brognard J; Granville CA; Zhang C; Gills JJ; Sayyah J; Dennis PA
Carcinogenesis; 2005 Jul; 26(7):1182-95. PubMed ID: 15790591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
